Aptamer Sciences Stock Current Valuation
| 291650 Stock | KRW 1,816 73.00 3.86% |
Valuation analysis of Aptamer Sciences helps investors to measure Aptamer Sciences' intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns.
Overvalued
Today
Please note that Aptamer Sciences' price fluctuation is very steady at this time. Calculation of the real value of Aptamer Sciences is based on 3 months time horizon. Increasing Aptamer Sciences' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Aptamer Sciences is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Aptamer Stock. However, Aptamer Sciences' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 1816.0 | Real 1644.06 | Hype 1816.0 | Naive 1959.53 |
The real value of Aptamer Stock, also known as its intrinsic value, is the underlying worth of Aptamer Sciences Company, which is reflected in its stock price. It is based on Aptamer Sciences' financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Aptamer Sciences' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Aptamer Sciences helps investors to forecast how Aptamer stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Aptamer Sciences more accurately as focusing exclusively on Aptamer Sciences' fundamentals will not take into account other important factors: Aptamer Sciences Company Current Valuation Analysis
Aptamer Sciences' Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Aptamer Sciences Current Valuation | 169.03 B |
Most of Aptamer Sciences' fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Aptamer Sciences is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, Aptamer Sciences has a Current Valuation of 169.03 B. This is much higher than that of the sector and significantly higher than that of the Current Valuation industry. The current valuation for all Republic of Korea stocks is notably lower than that of the firm.
Aptamer Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Aptamer Sciences' direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Aptamer Sciences could also be used in its relative valuation, which is a method of valuing Aptamer Sciences by comparing valuation metrics of similar companies.Aptamer Sciences is currently under evaluation in current valuation category among its peers.
Aptamer Fundamentals
| Return On Equity | -19.57 | |||
| Return On Asset | -0.11 | |||
| Operating Margin | (14.32) % | |||
| Current Valuation | 169.03 B | |||
| Shares Owned By Insiders | 33.00 % | |||
| Shares Owned By Institutions | 0.30 % | |||
| Revenue | 269.28 M | |||
| Gross Profit | 157.44 M | |||
| EBITDA | (3.49 B) | |||
| Net Income | (3.83 B) | |||
| Cash And Equivalents | 1.01 B | |||
| Total Debt | 68.63 M | |||
| Cash Flow From Operations | (3.47 B) | |||
| Market Capitalization | 74.03 B | |||
| Total Asset | 33.26 B | |||
| Net Asset | 33.26 B |
About Aptamer Sciences Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Aptamer Sciences's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Aptamer Sciences using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Aptamer Sciences based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with Aptamer Sciences
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Aptamer Sciences position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Aptamer Sciences will appreciate offsetting losses from the drop in the long position's value.Moving against Aptamer Stock
The ability to find closely correlated positions to Aptamer Sciences could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Aptamer Sciences when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Aptamer Sciences - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Aptamer Sciences to buy it.
The correlation of Aptamer Sciences is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Aptamer Sciences moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Aptamer Sciences moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Aptamer Sciences can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Other Information on Investing in Aptamer Stock
Aptamer Sciences financial ratios help investors to determine whether Aptamer Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Aptamer with respect to the benefits of owning Aptamer Sciences security.